RLYB
Rallybio Corporation Common Stock
stockNASDAQ

rallybio is a privately-held early-stage biotechnology company incorporated in january 2018. our ambition is to create a world-leading biotechnology organization that transforms the lives of patients with devastating disease, built around people with an outstanding track record in pharmaceutical research and development. we will work on highly-promising drug candidates that have strong biological rationales and that can be addressed using the well-validated therapeutic modalities of small molecules, engineered proteins, and antibodies. rallybio's founders are seasoned leaders from the biopharma industry with a wide breadth of research, development, and financial experience. the company is based in farmington, ct, at the university of connecticut's technology incubation program. we are assembling a small team of people with an outstanding track record in pharmaceutical research and development to search for and evaluate assets using a series of robust clinical and commercial filters tha

Rallybio Corporation Common Stock (NASDAQ:RLYB) stock price today is $17.11, and today's volume is 7,854. RLYB is up 2.088% today. The 30 day average volume is 9,692. RLYB market cap is $90.90M with 5.31M shares outstanding.